A systematic review of cannabidiol dosing in clinical populations

Key Findings:  Although larger confirmatory and efficacy clinical trials examining dosing in more detail for each medical context is required, this review summarises that CBD appears to offer a wide‐range of activity between 1 and 50 mg/kg/d, and there was a tendency of studies with positive outcomes to have used higher doses of CBD.

Type of Study:  Meta-analysis

Study Result:  Positive

Cannabinoids Studied:  Cannabidiol (CBD)

Form of Administration:  Not Applicable

Study Location(s):  United Kingdom, United States

Year of Pub:  2019

Link to study